What nonsteroidal anti-inflammatory drugs (NSAIDs) are recommended for adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NSAIDs Recommended for Adolescents

Ibuprofen is the first-line NSAID for adolescents aged 12-17 years, with naproxen as the preferred alternative for chronic inflammatory conditions. 1

First-Line NSAIDs for Acute Pain and Fever

Ibuprofen is the primary recommended NSAID for adolescents:

  • Approved for use in children ≥3 months of age and is the only NSAID with this broad pediatric approval 2
  • Dose should be appropriate for body weight 1
  • Superior safety profile compared to other NSAIDs in the pediatric population 2
  • Effective for acute pain, fever, and inflammatory conditions 3, 2

Naproxen is the preferred NSAID for chronic inflammatory conditions:

  • Specifically recommended by the American Academy of Pediatrics for juvenile idiopathic arthritis due to established efficacy and safety profile 4, 5
  • Better-established safety profile than alternatives like diclofenac, with FDA/EMA approval for pediatric use 5
  • Can be used as adjunct therapy for pain and inflammation 4, 6

Additional NSAIDs for Specific Indications

For migraine in adolescents aged 12-17 years:

  • Multiple NSAIDs are approved for acute migraine treatment 1
  • Ibuprofen remains first-line medication at weight-appropriate dosing 1

Ketorolac for severe acute pain:

  • 60 mg IM every 15-30 minutes, maximum 120 mg per day, treatment not to exceed 5 days 1
  • Reserved for severe postoperative pain in adolescents ≥1 year 3
  • Controversy exists regarding use after tonsillectomy due to bleeding risk 3

Diclofenac can be considered:

  • May be used at physician discretion, though naproxen is preferred 5
  • Requires baseline monitoring: blood pressure, serum creatinine, liver enzymes, and CBC before prescribing 5

NSAIDs to Avoid in Adolescents

Aspirin (acetylsalicylic acid):

  • Not recommended for children and adolescents due to risk of Reye's syndrome 4
  • Associated with more adverse effects compared to other NSAIDs 3
  • Exception: Kawasaki disease treatment in combination with intravenous immunoglobulins 3

Important Safety Considerations

Contraindications across all NSAIDs:

  • Dehydration, diarrhea, or vomiting (increases renal damage risk) 2
  • Known sensitivity to NSAIDs 2
  • Wheezing, persistent asthma, or active varicella infection 2
  • NSAID-induced asthma history 1

Common adverse effects to monitor:

  • Gastrointestinal upset (diarrhea, nausea, constipation, abdominal pain) 3
  • Headache, dizziness, rash 3
  • Renal impairment (especially with dehydration) 2

Monitoring requirements for chronic NSAID use:

  • CBC, liver function tests, and renal function tests every 6-12 months 6
  • Blood pressure monitoring 5

Clinical Pitfalls to Avoid

  • Do not use ibuprofen primarily as an antipyretic except in rare cases; it should be reserved for inflammatory pain 2
  • Do not delay disease-modifying therapy (like methotrexate) when NSAIDs are used for juvenile idiopathic arthritis—NSAIDs are adjunct therapy only 4
  • Avoid chronic low-dose glucocorticoids in adolescents with musculoskeletal pain 6
  • Never administer NSAIDs to dehydrated patients or those with active gastrointestinal symptoms 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Naproxen Dosing for Juvenile Idiopathic Arthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diclofenac Use in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Arm and Leg Pain in a Child After Negative JIA and Hypermobility Syndrome Evaluations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.